Literature DB >> 7645676

A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonists.

J P Tillement1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7645676     DOI： 10.1111/j.1398-9995.1995.tb04258.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  3 in total

1.  Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers.

Authors:  G Peytavin; C Gautran; C Otoul; A C Cremieux; B Moulaert; F Delatour; M Melac; M Strolin-Benedetti; R Farinotti
Journal:  Eur J Clin Pharmacol       Date:  2005-05-12       Impact factor: 2.953

2.  Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.

Authors:  Maria Pitsiu; Ziad Hussein; Oneeb Majid; Leon Aarons; Marc de Longueville; Armel Stockis
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

3.  Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria.

Authors:  E Nettis; G F Calogiuri; E Di Leo; F Cardinale; L Macchia; A Ferrannini; A Vacca
Journal:  J Asthma Allergy       Date:  2008-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.